Advertising

Novo Nordisk's Ozempic takes on Lilly's Trulicity in DTC showdown

Novo Nordisk's Ozempic takes on Lilly's Trulicity in DTC showdown

By

The two diabetes rivals air competing TV spots as they compete for GLP-1 supremacy.

Media buyers form group to advance standards in POC

Media buyers form group to advance standards in POC

By

Among the group's members are media agencies that had pulled healthcare ad spend from the POC channel in the wake of a scandal 10 months ago.

Interview | Sonja Foster-Storch & Michael Austin, GSW

Interview | Sonja Foster-Storch & Michael Austin, GSW

Ad agency GSW and parent company Syneos Health are all about healthcare. A conversation with GSW's Sonja Foster-Storch, president, North America, and Michael Austin, managing director, creative and technology, on why that's important.

2018 Agency 100 preview: a complete guide to a year of disruption

2018 Agency 100 preview: a complete guide to a year of disruption

By

This year's version of the Agency 100 aims to give you the most complete guide to disruptions in the environment in which agencies operate, ranging from fresh data privacy and security worries, to newer kinds of innovation and enterprise technology work.

Bayer dropped pitchwoman for bobblehead to save money: lawsuit

Bayer dropped pitchwoman for bobblehead to save money: lawsuit

By

The lawyer for former spokesperson Phoebe Jonas said Bayer created "a big headache for everyone."

Global ad investment to grow 4.5% in 2018

Global ad investment to grow 4.5% in 2018

New advertising will account for a $24 billion investment this year.

What CMOs are thinking in Cannes

What CMOs are thinking in Cannes

By

As the Cannes CMO Growth Council meets, marketers weigh in on what they're looking to gain from the Festival and this year's changes.

FBI probes media trading practices in the US

FBI probes media trading practices in the US

By

The Federal Bureau of Investigation is looking into media trading and transparency in the US advertising market.

Former JWT chief Gustavo Martinez exits WPP two years after sexual harassment row

Former JWT chief Gustavo Martinez exits WPP two years after sexual harassment row

By

Former JWT global chief executive Gustavo Martinez has departed WPP in a sign that the ad group's new leadership wants to draw a line under his controversial tenure.

Is it time for pharma ad agencies to reboot?

Is it time for pharma ad agencies to reboot?

As global advertisers cut their spending, should the agency world take a hard look in the mirror?

WPP investor pressure to sell Kantar could open door to Sorrell acquisition spree

WPP investor pressure to sell Kantar could open door to Sorrell acquisition spree

Investor pressure is likely to force WPP into selling Kantar, possibly along with other assets - which could open opportunities for Sir Martin Sorrell's new vehicle S4 Capital.

Terry Savage: What Cannes should and shouldn't be

Terry Savage: What Cannes should and shouldn't be

"Creativity in 2018 comes from everywhere" Cannes Lions' outgoing chairman says, describing what's new this year and how it differs from his first ever Cannes in 1986.

One-word answers with Publicis Groupe chairman Maurice Lévy

One-word answers with Publicis Groupe chairman Maurice Lévy

By

The former Publicis Groupe chief executive provides a word of advice (literally) to Sir Martin Sorrell on life "post-CEO", as well as the right time to retire and life with a beard.

Sorrell confirms adland return with 'tech, data and content'-focused S4 Capital

Sorrell confirms adland return with 'tech, data and content'-focused S4 Capital

Sir Martin Sorrell has confirmed details of his return to the front line of advertising only weeks after leaving WPP, with the launch of a new "multinational communication services business".

Rethinking disability targeting

Rethinking disability targeting

If we properly and intentionally use the power of targeted marketing on behalf of our disabled customers, we might drive real value for an audience we've ignored for too long.

MM&M Hall of Femme 2018: The profiles

MM&M Hall of Femme 2018: The profiles

MM&M is honoring 15 of the most-senior women in healthcare along with 20 Women to Watch who are changing the industry.

Susan Lodise, Publicis

Susan Lodise, Publicis

Susan Lodise is SVP, group account director of Publicis.

Making headlines: Key moments throughout Martin Sorrell's historic career

Making headlines: Key moments throughout Martin Sorrell's historic career

A divisive figure, Sorrell's rise to the top of the ad industry was never dull. Here, we outline the key moments.

Whither the pharma Grand Prix? Questions abound in run-up to Cannes health fest

Whither the pharma Grand Prix? Questions abound in run-up to Cannes health fest

Whether jurors will award a pharma Grand Prix, and whether US pharma will show up, are two open questions in the run-up to Lions Health.

17 days that rocked WPP

17 days that rocked WPP

By

To say that Sir Martin Sorrell's rapid departure from WPP was a seismic event is an understatement. So just what happened in the days leading up to the fall of its CEO?

WPP chairman Quarta should be ousted over Sorrell report, advisory group tells shareholders

WPP chairman Quarta should be ousted over Sorrell report, advisory group tells shareholders

Roberto Quarta faces a potential shareholder revolt at next month's AGM after advisory group Glass Lewis recommended that shareholders vote against his re-election.

Long live the king: reflections on Sorrell's reign

By

Sorrell was good copy. He got into bruising takeover fights, took on media owners in trading negotiations, sued rivals and former employees, and clashed repeatedly with WPP's shareholders over his pay.

Sorrell praises Trump economy, warns about Amazon, China

Sorrell praises Trump economy, warns about Amazon, China

The former WPP chief executive shared his view on technology, the economy, and politics on Tuesday at Techonomy NYC 18.

Cannabis gets the iPhone treatment

Cannabis gets the iPhone treatment

By

Thanks to legalization, a new breed of startups are changing the nature of cannabis advertising.

Marketers share how they use ad safety tech to help pharma clients feel comfortable

Marketers discuss the role of ad safety tech in helping pharma clients feel comfortable with ads in non-endemic media.

Six weeks until the Cannes Lions: Here's what we know

Six weeks until the Cannes Lions: Here's what we know

Record year for brands, fewer celebrities, lower volume of entries expected and much more.

How pharma and healthcare shifted strategies post-blockbuster drug success

How pharma and healthcare shifted strategies post-blockbuster drug success

Remedy Health Media's Mike Collins discusses ways pharma and healthcare companies have shifted their strategies in the years after the success of blockbuster drugs.

Health brands need to consider the human side of patients, HCPs, and stakeholders

Health brands need to consider the human side of patients, HCPs, and stakeholders

Croom Lawrence and Kent Groves of Merkle Health explain being human.

6 campaigns using real patients as advocates for orphan drugs

6 campaigns using real patients as advocates for orphan drugs

Dawn Hastings, associate creative director, Dudnyk, says using patients in campaigns for orphan drugs makes a brand's audience feel obligated to act.

Data-driven. Obsessive. A little pushy. Meet this year's Top 40 Healthcare Transformers

Data-driven. Obsessive. A little pushy. Meet this year's Top 40 Healthcare Transformers

By

Those on the vanguard of transformation include a number of upstarts and veteran gurus taking on historic challenges plaguing health data.